>Why shouldn't Novo attempt to buy GTC, given the prospective economics [of NovoSeven] beyond 2012?<
Good question.
NVO is working on a follow-on to NovoSeven called NN1731 (#msg-18366299); however, with much less risk, NVO could acquire a patent-protected rFVIIa product from GTC and the rest of the company’s assets to boot.
When we talk about whether GTC will reach profitability in mid 2008, we have to keep in mind that GTC may not be a standalone business by that time.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.